A/HRC/7/30 page 6 6. The Government of Bosnia and Herzegovina reported that full access to medication for HIV/AIDS and tuberculosis is free of charge and guaranteed for those who need it, and that malaria has been eradicated from the country. Medication for those diagnosed with HIV/AIDS is financed by health insurance funds. Additional support from the Global Fund has secured the purchase of equipment for CD4 count testing and viral load testing (polymerase chain reaction). Paediatric forms of HIV treatment have not been secured due to the low prevalence rate of HIV among children. 7. The Government of Canada, through its African Health Systems Initiative, will contribute US$ 450 million over the next decade to support country-led efforts to strengthen health systems, improve health outcomes and make progress towards the Millennium Development Goals. It has supported efforts in West African countries to develop new strategies to improve access to medicines and to take advantage of flexibilities available in the TRIPS Agreement. As the seventh-largest donor to the Global Fund, the Government also supports initiatives that directly target the provision of medicines and/or vaccines to developing countries. The Government also supports organizations such as the Canadian Red Cross, the GAVI Alliance, the Canadian International Immunization Initiative, the Micronutrient Initiative, the Global Tuberculosis Drug Facility, advance market commitments (AMCs) and United Nations agencies to: prevent and control malaria through the distribution of insecticide bed nets; provide new and underused vaccines to developing countries; immunize children; eliminate micronutrient deficiencies in children and women; develop safe, effective, affordable and universally accessible HIV vaccines; provide life-saving drugs to 10 million tuberculosis patients; and accelerate the development of an effective pneumococcal vaccine for developing countries. In 2007, an “Initiative to save a million lives” was announced by the Government to provide funding to train 40,000 health workers and to provide life-saving treatment for mothers and children suffering from malaria, measles and malnutrition. 8. In order to facilitate access, the Government of Canada also instated a new tax incentive to encourage pharmaceutical manufacturers to donate medicines to developing countries. In 2005, the Canada Access to Medicines Regime (CAMR) entered into force and amended the Patent Act. This statutory measure has enabled Canadian pharmaceutical manufacturers to apply for a compulsory licence to export a lower-cost, generic version of patented pharmaceutical products to developing or least-developed countries that are unable to manufacture their own. CAMR recently granted authorization to export a fixed-dose, triple-combination HIV/AIDS drug to a developing country. 9. The Government of Croatia indicated that it had a centralized system of care for people living with HIV who are treated at the HIV/AIDS Centre at the University Hospital of Infectious Diseases in Zagreb. The following antiretroviral drugs are available at the centre: zidovudine, lamivudine, zidovudine plus lamivudine combination treatment, stavudine, didanosine, abacavir, nevirapine, efavirenz, indinavir and lopinavir/ritonavir. Antiretrovirals are provided free of charge through the National Health Insurance system and coverage is universal. The average monthly cost of antiretrovirals for one patient is approximately US$ 950. Through support from the Global Fund, an outpatient centre for HIV/AIDS was established in June 2005 at the University Hospital, which also provides psychosocial support as an integral part of health care. Currently, there are 416 patients at the centre, of whom 342 receive antiretroviral treatment.